Dld Asset Management, LP Ayala Pharmaceuticals, Inc. Transaction History

Dld Asset Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.99 - $4.15 $6,633 - $27,805	-6,700 Reduced 3.88%	166,167 $181,000
Q1 2022 May 13, 2022	BUY	$3.5 - $9.11 $51,222 - $133,324	14,635 Added 9.25%	172,867 $688,000
Q4 2021 Feb 14, 2022	BUY	$8.32 - $12.45 $1.32 Million - $1.97 Million	158,232 New	158,232 $1.35 Million

Ticker AYLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,833,300
Description
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.